Axial Spondyloarthritis More Common than Previously Thought
Axial spondyloarthritis (SpA) often goes undiagnosed and is more common than previously thought, a study shows.
Diagnosing axSpA and AS in Primary Care
The diagnosis and treatment of spondyloarthritis (axSpA) and ankylosing spondylitis (AS) for primary healthcare providers.
High BMI Not a Factor in Axial Spondyloarthritis
Researchers say it's not necessary to take high body mass index into account in axial spondyloarthritis.
TNFis Pose No Cancer Risk for Spondyloarthritis Patients
Patients with spondyloarthritis can confidently undergo treatment with tumor necrosis factor ⍺ inhibitors (TNFi) without fear of cancer risk.
Review: Treatment Options for Spondyloarthritis
Many new treatments for axial spondyloarthritis (SpA) have been introduced in recent years. This review summarizes current treatments for SpA.
Non-Radiographic Axial Spondyloarthritis Treatment Guidelines
New treatment guidelines for non-radiographic axial spondyloarthritis call for treatment with TNF blockers if NSAIDs fail.
Do You and Your Patients Agree on Treatment Goals?
Research highlights a need for closer partnerships between physicians and patients to set shared treatment goals.
By clicking Accept, you agree to become a member of the UBM Medica Community.